prikaz prve stranice dokumenta Kardiovaskularne bolesti i androgen deprivacijska terapija
  Download
PDF 207.48 KB
Professional paper - Professional paper
Kardiovaskularne bolesti i androgen deprivacijska terapija
Acta clinica Croatica, 58 (2019), Supplement 2; 60-63. https://doi.org/10.20471/acc.2019.58.s2.09
Boban, Marko

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Boban, M. (2019). Kardiovaskularne bolesti i androgen deprivacijska terapija. Acta clinica Croatica, 58. (Supplement 2), 60-63. doi: 10.20471/acc.2019.58.s2.09

Boban, Marko. "Kardiovaskularne bolesti i androgen deprivacijska terapija." Acta clinica Croatica, vol. 58, no. Supplement 2, 2019, pp. 60-63. https://doi.org/10.20471/acc.2019.58.s2.09

Boban, Marko. "Kardiovaskularne bolesti i androgen deprivacijska terapija." Acta clinica Croatica 58, no. Supplement 2 (2019): 60-63. https://doi.org/10.20471/acc.2019.58.s2.09

Boban, M. (2019) 'Kardiovaskularne bolesti i androgen deprivacijska terapija', Acta clinica Croatica, 58(Supplement 2), pp. 60-63. doi: 10.20471/acc.2019.58.s2.09

Boban M. Kardiovaskularne bolesti i androgen deprivacijska terapija. Acta clinica Croatica [Internet]. 2019 [cited 2024 May 08];58(Supplement 2):60-63. doi: 10.20471/acc.2019.58.s2.09

M. Boban, "Kardiovaskularne bolesti i androgen deprivacijska terapija", Acta clinica Croatica, vol. 58, no. Supplement 2, pp. 60-63, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:749508. [Accessed: 08 May 2024]

Metadata
Title (croatian)Kardiovaskularne bolesti i androgen deprivacijska terapija
Title (english)Cardiovascular Diseases and Androgen Deprivation Therapy
AuthorMarko Boban
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (croatian)
Vodeći uzrok smrti u bolesnika s karcinomom prostate su kardiovaskularne bolesti. Terapija deprivacije androgena (ADT ) temelj je liječenja raka prostate. Potonja ima brojne nepovoljne učinke na kardiovaskularno zdravlje. ADT pogoršava metabolički profil, inzulinsku rezistenciju i metabolizam glukoze, uzrokuje gubitak mišićne tjelesne mase i povećanje mase masnog tkiva, posreduje u razvoju pretilosti, pogoršava aterosklerozu i dovodi do zatajenja srca. Valja naglasiti u studijama pronađenu dodatno povećanu učestalost bolesti koronarnih arterija, moždanog udara, infarkta miokarda i kardiovaskularnog mortaliteta kod bolesnika s karcinomom prostate i ADT-om. Iz navedenih razloga potrebna je dodatna briga oko prevencije i liječenja kardiovaskularnih bolesti, a navedeno bi trebalo postati standard zdravstvene skrbi.
Abstract (english)
The leading cause of death in patients with prostate cancer are cardiovascular diseases. Androgen deprivation therapy is the mainstay of treatment in prostate cancers. The latter has numerous perplexed disadvantaging effects to cardiovascular health. ADT alternates the metabolic profile, insulin resistance and glucose metabolism, causes loss of lean body mass, an increase in adipose tissue, obesity, worsening of atherosclerosis and heart failure. It is important to point out that prostate cancer survivors have increased prevalence of coronary artery disease, cerebrovascular stroke, myocardial infarctions and cardiovascular mortality. Due to these reasons particular care on prevention and treatment of cardiovascular diseases should become a standard of care in patients with prostate cancer.
Keywords (croatian)
Keywords (english)
Languagecroatian
Languageenglish
Publication typeProfessional paper - Professional paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleActa clinica Croatica
Numberingvol. 58, no. Supplement 2, pp. 60-63
p-ISSN0353-9466
e-ISSN1333-9451
DOIhttps://doi.org/10.20471/acc.2019.58.s2.09
URN:NBNurn:nbn:hr:184:749508
Publication2019
Document URLhttps://hrcak.srce.hr/234268
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) icon
Created on2020-02-18 12:12:45